The most common side effects of Wegovy include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
The primary concern for blood services is ensuring the safety of both parties involved in the donation process
Third-party data: Some pharmacies rely on stability data from ingredient suppliers or third-party laboratories
Effect of rhubaric acid on prevention and treatment of nonalcoholic fatty liver disease induced by high fat diet in rats
BPC-157 is also named on WADA's Prohibited List under section S0 (Non-Approved Substances), the first time WADA named a specific substance by name as an example within that category (added for the 2022 List)
On average, the sale price of a biosimilar is half the cost of its brand-name counterpart, according to data from the Association for Accessible Medicines